|
Volumn 26, Issue 5, 2008, Pages 495-
|
HIV vaccine trials in India
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE TGAAC09;
DRUG SAFETY;
DRUG TOLERABILITY;
ENVIRONMENTAL FACTOR;
HEREDITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOGENICITY;
INDIA;
LETTER;
PRIORITY JOURNAL;
VACCINATION;
AIDS VACCINES;
CLINICAL TRIALS AS TOPIC;
HIV INFECTIONS;
HUMANS;
INDIA;
|
EID: 43449111778
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0508-495 Document Type: Letter |
Times cited : (5)
|
References (1)
|